PCSK9|https://phgkb.cdc.gov/GAPPKB/phgHome.do|Updates on Specific Diseases

https://phgkb.cdc.gov/GAPPKB/phgHome.do

From Guideline Database

This database contains updated guidelines, policies and recommendations on genomic research and practice, as provided by professional organizations, federal advisory groups, expert panels and policy groups.

---

• Recommendations for the management of patients with homozygous familial hypercholesterolaemia: overview of a new European Atherosclerosis Society consensus statement.  
  Published 2014 (European Atherosclerosis Society )
• [Diagnostic and treatment of familial hypercholesterolemia (FH) in adult: guidelines from the New French Society of Atherosclerosis (NSFA)].  
  Published 2013 (New French Society of Atherosclerosis (NSFA))
• HEART UK statement on the management of homozygous familial hypercholesterolaemia in the United Kingdom.  
  Published 2016 (HEART UK Medical Scientific and Research Committee)
• Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society Severe Familial Hypercholesterolemia Panel.  
  Published 2016 (International Atherosclerosis Society Severe Familial Hypercholesterolemia Panel)
• Expert consensus on the rational clinical use of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors.  
  Published 2016 (Expert panel)

more